12th June 2023 Content supplied by: ZeptoMetrix
Is Your Lab Ready to Deliver Ultimate Confidence in Women's Health Testing?
CDC finds alarming trends in STIs in recent report - Is Your Lab Ready to Deliver Ultimate Confidence in Women's Health Testing?
The CDC released its final surveillance report stating there were over 2.3 million cases of Chlamydia and Gonorrhea in 2021. Gonorrhoeae and Chlamydia rates have increased by over 4% since 2020, however, it has yet to return to pre-pandemic rates. The CDC has called on healthcare providers to contribute to STI prevention by offering more accessible testing.
Reach the highest confidence.
ZeptoMetrix® NATtrol™ Women’s Health & STI products are the most trusted brand in third-party molecular diagnostic QC. Utilizing ZeptoMetrix NATtrol Molecular Controls on a consistent basis helps to monitor testing performance and provides additional confidence in the quality and reliability of clinical laboratory operations.
Our main STI controls and panels include the following:
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Trichomonas vaginalis (TV)
- Bacterial vaginosis (BV)
- Group B Streptococcus (GBS)
- Mycoplasma genitalium (MGN)
Visit our website to learn more about these critical solutions or to get connected with one of our specialists.
Click here to contact us, or use the green "Request Information" button below to email directly.
Date Published: 12th June 2023
Source article link: View